Neurologic uses of botulinum neurotoxin type A

by John P. Ney, Kevin R. Joseph
Neuropsychiatric Disease and Treatment ()

Abstract

This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.

Cite this document (BETA)

Readership Statistics

24 Readers on Mendeley
by Discipline
 
50% Medicine
 
33% Biological Sciences
 
8% Psychology
by Academic Status
 
29% Student (Master)
 
21% Student (Bachelor)
 
8% Researcher (at an Academic Institution)
by Country
 
4% United Kingdom
 
4% Brazil
 
4% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in